Matthias Sury

Matthias Sury, PhD, has a diverse work experience spanning multiple roles and organizations. Matthias started their career as a Postdoc at the Institute for Infectious Diseases, University of Bern in 2008, and then moved to the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, where they continued their Postdoc role from 2008 to 2012. In 2013, they joined SYNLAB pharma institute AG as a Study Director and worked there until 2018. During this time, they gained expertise in overseeing studies. Since 2018, Matthias has been working at Celerion, where they have held several roles, including Manager Method Development LC-MS, Technical Director LC-MS, and currently, they serve as the Director LC-MS. Matthias'sexperience at Celerion has focused on LC-MS applications and method development.

Matthias Sury, PhD, obtained their Master's degree in Cell Biology with a focus on Immunology and Microbiology from the University of Bern in 2004. Matthias then pursued their Doctor of Philosophy (PhD) in Molecular Biology from the Institute for Infectious Diseases at the University of Bern, which was completed in 2008.